Trademark: 98186714
Word
OFEZUMIR
Status Date
Tuesday, February 27, 2024
Filing Date
Tuesday, September 19, 2023
Published for Opposition
Tuesday, February 27, 2024
5 Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders
16 Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building
44 Providing medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic and dermatological disorders
The mark consists of the word OFEZUMIR and a design appearing on the left of the wording consisting of two outlined rectangles appearing in angle with one another with a solid rectangle intersecting between the outlined rectangles.
Color is not claimed as a feature of the mark.
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 27, 2024
Published For Opposition
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 19, 2024
Approved For Pub - Principal Register
Jan 17, 2024
Assigned To Examiner
Oct 6, 2023
Notice Of Design Search Code E-Mailed
Oct 5, 2023
New Application Office Supplied Data Entered
Sep 22, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24